|
STK38 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.363000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.309400E-01 |
| Normal-vs-Stage2 |
5.196000E-01 |
| Normal-vs-Stage3 |
7.722000E-01 |
| Normal-vs-Stage4 |
7.669400E-01 |
| Stage1-vs-Stage2 |
2.737000E-01 |
| Stage1-vs-Stage3 |
9.857800E-01 |
| Stage1-vs-Stage4 |
9.994600E-01 |
| Stage2-vs-Stage3 |
3.529800E-01 |
| Stage2-vs-Stage4 |
3.685400E-01 |
| Stage3-vs-Stage4 |
9.896200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.156800E-01 |
| Normal-vs-AfricanAmerican |
2.517600E-01 |
| Normal-vs-Asian |
2.059000E-03 |
| Caucasian-vs-AfricanAmerican |
1.432770E-01 |
| Caucasian-vs-Asian |
4.702700E-03 |
| AfricanAmerican-vs-Asian |
8.022400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.364000E-01 |
| Normal-vs-Female |
1.697440E-01 |
| Male-vs-Female |
1.235540E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.172400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.297000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.199200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.144000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.006300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.257800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.053000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.502410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.472000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.282400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.734190E-01 |
| Normal-vs-Grade 2 |
5.010000E-01 |
| Normal-vs-Grade 3 |
9.020400E-01 |
| Normal-vs-Grade 4 |
5.877600E-01 |
| Grade 1-vs-Grade 2 |
3.721600E-01 |
| Grade 1-vs-Grade 3 |
2.258000E-01 |
| Grade 1-vs-Grade 4 |
1.445230E-01 |
| Grade 2-vs-Grade 3 |
4.400400E-01 |
| Grade 2-vs-Grade 4 |
1.977770E-01 |
| Grade 3-vs-Grade 4 |
4.483400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.477800E-02 |
| Normal-vs-ccB subtype |
3.684200E-01 |
| ccA subtype-vs-ccB subtype |
2.075200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.647800E-01 |
| Normal-vs-N1 |
6.531000E-01 |
| N0-vs-N1 |
9.026200E-01 |
|
|
